Literature DB >> 12627280

Respiratory disease due to parainfluenza virus in adult leukemia patients.

J A Marcolini1, S Malik, D Suki, E Whimbey, G P Bodey.   

Abstract

Reports of human parainfluenza viruses (HPIV) in patients with leukemia have been limited to a few cases or as a portion of general surveys. In order to expand the knowledge of these infections in this patient group, the frequency and clinical course of HPIV infections was determined among 1,787 patients with leukemia treated at The University of Texas M.D. Anderson Cancer Center between July 1994 and December 1997. HPIV was isolated from 47 (6.2%) of the 770 patients who were cultured for respiratory viruses. HPIV type 3 accounted for 39 of the 47 HPIV infections. Twenty-six patients developed pneumonia, and the associated mortality was 27%. Multivariate analysis revealed that a low absolute lymphocyte count and pneumonia were associated with increased mortality. Concurrent respiratory and other infections were associated with an increased frequency of pneumonia. Only five patients with pneumonia received antiviral therapy and four of them survived the infection. HPIV infection in leukemic patients is frequently associated with pneumonia and the mortality rate from pneumonia is substantial among lymphopenic patients.

Entities:  

Mesh:

Year:  2003        PMID: 12627280     DOI: 10.1007/s10096-002-0864-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Surveillance for outbreaks of respiratory tract infections in nursing homes.

Authors:  M Loeb; A McGeer; M McArthur; R W Peeling; M Petric; A E Simor
Journal:  CMAJ       Date:  2000-04-18       Impact factor: 8.262

2.  Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.

Authors:  S Chakrabarti; K E Collingham; K Holder; S Oyaide; D Pillay; D W Milligan
Journal:  Clin Infect Dis       Date:  2000-12       Impact factor: 9.079

3.  A serious outbreak of parainfluenza type 3 on a nursing unit.

Authors:  J Todd Faulks; P J Drinka; P Shult
Journal:  J Am Geriatr Soc       Date:  2000-10       Impact factor: 5.562

4.  Parainfluenza virus type 3 infections in a hematology unit.

Authors:  U Hohenthal; J Nikoskelainen; R Vainionpää; R Peltonen; M Routamaa; M Itälä; P Kotilainen
Journal:  Bone Marrow Transplant       Date:  2001-02       Impact factor: 5.483

5.  Impact of respiratory virus infections on persons with chronic underlying conditions.

Authors:  W P Glezen; S B Greenberg; R L Atmar; P A Piedra; R B Couch
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

6.  Epidemiology of acute lower respiratory disease in children.

Authors:  P Glezen; F W Denny
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

7.  Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.

Authors:  W G Nichols; L Corey; T Gooley; C Davis; M Boeckh
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

8.  Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old.

Authors:  G Reed; P H Jewett; J Thompson; S Tollefson; P F Wright
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

Review 9.  Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.

Authors:  C H Wendt; M I Hertz
Journal:  Semin Respir Infect       Date:  1995-12

10.  Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment.

Authors:  J Elizaga; E Olavarria; J Apperley; J Goldman; K Ward
Journal:  Clin Infect Dis       Date:  2001-01-25       Impact factor: 9.079

View more
  17 in total

1.  Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.

Authors:  Makiko Watanabe; Vasiliy P Mishin; Scott A Brown; Charles J Russell; Kelli Boyd; Y Sudhakara Babu; Garry Taylor; Xiaoping Xiong; Xiaowei Yan; Allen Portner; Irina V Alymova
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

2.  Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery.

Authors:  Shohreh F Farzan; Laura M Palermo; Christine C Yokoyama; Gianmarco Orefice; Micaela Fornabaio; Aurijit Sarkar; Glen E Kellogg; Olga Greengard; Matteo Porotto; Anne Moscona
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

3.  Parainfluenza virus infections in children with hematologic malignancies.

Authors:  Ashok Srinivasan; Chong Wang; Jie Yang; Hiroto Inaba; Jerry L Shenep; Wing H Leung; Randall T Hayden
Journal:  Pediatr Infect Dis J       Date:  2011-10       Impact factor: 2.129

Review 4.  Airway disease in hematologic malignancies.

Authors:  Ricardo J José; Burton F Dickey; Ajay Sheshadri
Journal:  Expert Rev Respir Med       Date:  2022-02-21       Impact factor: 4.300

Review 5.  Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.

Authors:  Dimpy P Shah; Pankil K Shah; Jacques M Azzi; Roy F Chemaly
Journal:  Cancer Lett       Date:  2015-11-12       Impact factor: 8.679

6.  Current management of parainfluenza pneumonitis in immunocompromised patients: a review.

Authors:  Ann R Falsey
Journal:  Infect Drug Resist       Date:  2012-08-08       Impact factor: 4.003

Review 7.  Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus.

Authors:  Hans H Hirsch; Rodrigo Martino; Katherine N Ward; Michael Boeckh; Hermann Einsele; Per Ljungman
Journal:  Clin Infect Dis       Date:  2012-09-28       Impact factor: 9.079

8.  Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone.

Authors:  Heba H Mostafa; Peter Vogel; Ashok Srinivasan; Charles J Russell
Journal:  PLoS Pathog       Date:  2016-09-02       Impact factor: 6.823

9.  Characteristics of viral pneumonia in non-HIV immunocompromised and immunocompetent patients: a retrospective cohort study.

Authors:  Lijuan Li; Steven H Hsu; Chunlei Wang; Binbin Li; Lingxiao Sun; Jinying Shi; Yali Ren; Jinxiang Wang; Xiaoqi Zhang; Jiangbo Liu
Journal:  BMC Infect Dis       Date:  2021-08-06       Impact factor: 3.090

10.  Respiratory viral infections after hematopoietic stem cell transplantation in children.

Authors:  Jae Hong Choi; Eun Hwa Choi; Hyoung Jin Kang; Kyung Duk Park; Sung Sup Park; Hee Young Shin; Hoan Jong Lee; Hyo Seop Ahn
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.